Provided herein are methods and kits for making a targeted therapeutic for treating a
disease or condition. The therapeutic agents can be targeted to patient-specific
disease markers. In one of these methods, the method includes obtaining a biological sample from a patient having the
disease or condition, or who is at risk for developing the disease or condition. In this particular method, the sample includes a
population of diseased cells, screening a
library comprising proteins linked to their cognate mRNAs to identify mRNA-
protein pairs that bind to the diseased cells, isolating one or more proteins from the identified mRNA-
protein pairs, and conjugating the isolated
protein(s) to a therapeutic agent. Some of the methods further include preparing a
library with proteins linked to their cognate mRNAs. In certain of these methods, the preparation of the
library includes providing at least two candidate mRNA molecules in which each of the mRNA molecules includes a cross-
linker, translating at least two of the candidate mRNA molecules to generate at least one translated protein, and linking at least one of the candidate mRNA molecules to its corresponding translated protein via the cross-
linker to form at least one cognate pair.